Effect of Tenofovir Disoproxil Fumarate and Emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: A pilot, randomized, open-label phase 2 trial

DOI record: { "DOI": "10.1016/j.eclinm.2021.100993", "ISSN": [ "2589-5370" ], "URL": "http://dx.doi.org/10.1016/j.eclinm.2021.100993", "alternative-id": [ "S258953702100273X" ], "article-number": "100993", "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Effect of Tenofovir Disoproxil Fumarate and Emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: A pilot, randomized, open-label phase 2 trial" }, { "label": "Journal Title", "name": "journaltitle", "value": "eClinicalMedicine" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.eclinm.2021.100993" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2021 The Author(s). Published by Elsevier Ltd." } ], "author": [ { "ORCID": "https://orcid.org/0000-0002-4774-5590", "affiliation": [], "authenticated-orcid": false, "family": "Parienti", "given": "Jean-Jacques", "sequence": "first" }, { "affiliation": [], "family": "Prazuck", "given": "Thierry", "sequence": "additional" }, { "affiliation": [], "family": "Peyro-Saint-Paul", "given": "Laure", "sequence": "additional" }, { "affiliation": [], "family": "Fournier", "given": "Anna", "sequence": "additional" }, { "affiliation": [], "family": "Valentin", "given": "Cécile", "sequence": "additional" }, { "affiliation": [], "family": "Brucato", "given": "Sylvie", "sequence": "additional" }, { "affiliation": [], "family": "Verdon", "given": "Renaud", "sequence": "additional" }, { "affiliation": [], "family": "Sève", "given": "Aymeric", "sequence": "additional" }, { "affiliation": [], "family": "Colin", "given": "Mathilda", "sequence": "additional" }, { "affiliation": [], "family": "Lesne", "given": "Fabien", "sequence": "additional" }, { "affiliation": [], "family": "Guinard", "given": "Jérome", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-3672-9974", "affiliation": [], "authenticated-orcid": false, "family": "Ar Gouilh", "given": "Meriadeg", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0003-1584-2457", "affiliation": [], "authenticated-orcid": false, "family": "Dina", "given": "Julia", "sequence": "additional" }, { "affiliation": [], "family": "Vabret", "given": "Astrid", "sequence": "additional" }, { "affiliation": [], "family": "Hocqueloux", "given": "Laurent", "sequence": "additional" } ], "container-title": "eClinicalMedicine", "container-title-short": "eClinicalMedicine", "content-domain": { "crossmark-restriction": true, "domain": [ "thelancet.com", "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2021, 6, 27 ] ], "date-time": "2021-06-27T04:20:15Z", "timestamp": 1624767615000 }, "deposited": { "date-parts": [ [ 2022, 9, 3 ] ], "date-time": "2022-09-03T07:04:01Z", "timestamp": 1662188641000 }, "indexed": { "date-parts": [ [ 2025, 6, 15 ] ], "date-time": "2025-06-15T12:03:10Z", "timestamp": 1749988990961, "version": "3.40.5" }, "is-referenced-by-count": 49, "issued": { "date-parts": [ [ 2021, 8 ] ] }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 8, 1 ] ], "date-time": "2021-08-01T00:00:00Z", "timestamp": 1627776000000 } }, { "URL": "http://creativecommons.org/licenses/by/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 6, 10 ] ], "date-time": "2021-06-10T00:00:00Z", "timestamp": 1623283200000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S258953702100273X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S258953702100273X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "100993", "prefix": "10.1016", "published": { "date-parts": [ [ 2021, 8 ] ] }, "published-print": { "date-parts": [ [ 2021, 8 ] ] }, "publisher": "Elsevier BV", "reference": [ { "key": "10.1016/j.eclinm.2021.100993_bib0001", "unstructured": "COVID-19 Map. Johns Hopkins Coronavirus Resource Center. https://coronavirus.jhu.edu/map.html (accessed March 29, 2021)." }, { "DOI": "10.1371/journal.pone.0242398", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0002", "unstructured": "Wong DWS, Li Y. Spreading of COVID-19: Density matters. PLoS One2020; 15: e0242398." }, { "DOI": "10.1056/NEJMc2001272", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0003", "unstructured": "Phan LT, Nguyen TV, Luong QC, et al. Importation and human-to-human transmission of a Novel Coronavirus in Vietnam. N Engl J Med2020; 382: 872–4." }, { "DOI": "10.1056/NEJMoa2008457", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0004", "unstructured": "Arons MM, Hatfield KM, Reddy SC, et al. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. New England Journal of Medicine2020; published online April 24. DOI:10.1056/NEJMoa2008457." }, { "DOI": "10.1016/j.cell.2020.08.012", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0005", "unstructured": "Starr TN, Greaney AJ, Hilton SK, et al. Deep Mutational Scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 Binding. Cell2020; 182: 1295-1310.e20." }, { "DOI": "10.1056/NEJMp2026913", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0006", "unstructured": "Gandhi M, Rutherford GW. Facial masking for COVID-19 — Potential for “Variolation” as we await a vaccine. New England Journal of Medicine2020; published online Sept 8. DOI:10.1056/NEJMp2026913." }, { "DOI": "10.1056/NEJMoa2029849", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0007", "unstructured": "Chen P, Nirula A, Heller B, et al. SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19. N Engl J Med2021; 384: 229–37." }, { "DOI": "10.1016/j.cell.2021.03.036", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0008", "unstructured": "Hoffmann M, Arora P, Groß R, et al. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies. Cell2021; published online March 20. DOI:10.1016/j.cell.2021.03.036." }, { "DOI": "10.1371/journal.pone.0011068", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0009", "unstructured": "Das M, Chu PL, Santos G-M, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS ONE2010; 5: e11068." }, { "DOI": "10.1177/096228029300200103", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0010", "unstructured": "Dietz K. The estimation of the basic reproduction number for infectious diseases. Stat Methods Med Res1993; 2: 23–41." }, { "key": "10.1016/j.eclinm.2021.100993_bib0011", "unstructured": "Painter W-P, Sheahan T, Baric R, et al. Reduction in infectious SARS-CoV-2 in treatment study of COVID-19 with MOLNUPIRAVIR. CROI Conference. https://www.croiconference.org/abstract/reduction-in-infectious-sars-cov-2-in-treatment-study-of-covid-19-with-molnupiravir/ (accessed May 18, 2021)." }, { "DOI": "10.1086/596482", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0012", "unstructured": "Parienti J-J, Bangsberg DR, Verdon R, Gardner EM. Better adherence with once-daily antiretroviral regimens: a meta-analysis. Clin Infect Dis2009; 48: 484–8." }, { "key": "10.1016/j.eclinm.2021.100993_bib0013", "unstructured": "WHO model list of essential medicines. https://www.who.int/publications-detail-redirect/WHOMVPEMPIAU2019.06 (accessed March 29, 2021)." }, { "DOI": "10.1016/j.lfs.2020.117592", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0014", "unstructured": "Elfiky AA. Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life Sci2020; 253: 117592." }, { "DOI": "10.1021/acs.jproteome.0c00392", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0015", "unstructured": "Chien M, Anderson TK, Jockusch S, et al. Nucleotide analogues as inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19. J Proteome Res2020; 19: 4690–7." }, { "DOI": "10.1128/AAC.01652-20", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0016", "unstructured": "Zandi K, Amblard F, Musall K, et al. Repurposing nucleoside analogs for human coronaviruses. Antimicrob Agents Chemother2020; 65. DOI:10.1128/AAC.01652-20." }, { "DOI": "10.21577/0103-5053.20200106", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0017", "unstructured": "Clososki GC, Soldi RA, Silva RM da, et al. Tenofovir Disoproxil Fumarate: New chemical developments and encouraging in vitro biological results for SARS-CoV-2. J Braz Chem Soc2020; 31: 1552–6." }, { "DOI": "10.1128/mBio.01114-20", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0018", "unstructured": "Park S-J, Yu K-M, Kim Y-I, et al. Antiviral Efficacies of FDA-approved drugs against SARS-CoV-2 infection in Ferrets. mBio2020; 11. DOI:10.1128/mBio.01114-20." }, { "DOI": "10.7326/M20-3689", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0019", "unstructured": "Del Amo J, Polo R, Moreno S, et al. Incidence and Severity of COVID-19 in HIV-positive persons receiving antiretroviral therapy : a cohort study. Ann Intern Med2020; 173: 536–41." }, { "DOI": "10.1101/2020.07.02.20145185", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0020", "unstructured": "Boulle A, Davies M-A, Hussey H, et al. Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa. Clin Infect Dis2020; published online Aug 29. DOI:10.1093/cid/ciaa1198." }, { "key": "10.1016/j.eclinm.2021.100993_bib0021", "unstructured": "Berenguer J, Diez C, Martin-Vincente M, et al. Prevalence and factors associated with SARS-CoV-2 antibodies in a SPANISH HIV Cohort. CROI Conference. https://www.croiconference.org/abstract/prevalence-and-factors-associated-with-sars-cov-2-antibodies-in-a-spanish-hiv-cohort/ (accessed March 30, 2021)." }, { "DOI": "10.1007/s15010-020-01438-z", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0022", "unstructured": "Härter G, Spinner CD, Roider J, et al. COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients. Infection2020; 48: 681–6." }, { "DOI": "10.1097/QAI.0000000000002450", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0023", "unstructured": "Gudipati S, Brar I, Murray S, McKinnon JE, Yared N, Markowitz N. Descriptive analysis of patients living with HIV affected by COVID-19. J Acquir Immune Defic Syndr2020; 85: 123–6." }, { "DOI": "10.1016/j.ijid.2020.09.1436", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0024", "unstructured": "Isernia V, Julia Z, Le Gac S, et al. SARS-COV2 infection in 30 HIV-infected patients followed-up in a French University Hospital. Int J Infect Dis2020; 101: 49–51." }, { "key": "10.1016/j.eclinm.2021.100993_bib0025", "unstructured": "Molina J-M, Capitant C, Spire B, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med2015; 373: 2237–46." }, { "DOI": "10.1093/cid/ciaa1009", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0026", "unstructured": "Mitjà O, Corbacho-Monné M, Ubals M, et al. Hydroxychloroquine for early treatment of adults with mild Covid-19: a randomized-controlled trial. Clin Infect Dis2020; published online July 16. DOI:10.1093/cid/ciaa1009." }, { "key": "10.1016/j.eclinm.2021.100993_bib0027", "unstructured": "Skipper CP, Pastick KA, Engen NW, et al. Hydroxychloroquine in non-hospitalized adults with early covid-19 : a randomized trial. Ann Intern Med2020; 173: 623–31." }, { "key": "10.1016/j.eclinm.2021.100993_bib0028", "unstructured": "WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection. a minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis2020; 20: e192–7." }, { "DOI": "10.1056/NEJMcp2009249", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0029", "unstructured": "Gandhi RT, Lynch JB, Del Rio C. Mild or moderate Covid-19. N Engl J Med2020; 383: 1757–66." }, { "DOI": "10.1073/pnas.2017962118", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0030", "unstructured": "Néant N, Lingas G, Le Hingrat Q, et al. Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort. Proc Natl Acad Sci U S A2021; 118. DOI:10.1073/pnas.2017962118." }, { "DOI": "10.1097/EDE.0000000000001235", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0031", "unstructured": "Del Amo J, Polo R, Moreno S, et al. Antiretrovirals and risk of COVID-19 diagnosis and hospitalization in HIV-positive persons. Epidemiology2020; 31: e49–51." }, { "DOI": "10.1093/ofid/ofaa455", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0032", "unstructured": "Ayerdi O, Puerta T, Clavo P, et al. Preventive Efficacy of Tenofovir/Emtricitabine against severe acute respiratory syndrome coronavirus 2 Among Pre-Exposure Prophylaxis Users. Open Forum Infect Dis2020; 7: ofaa455." }, { "key": "10.1016/j.eclinm.2021.100993_bib0033", "unstructured": "Bernal JL, Andrews N, Gower C, et al. Effectiveness of BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on mortality following COVID-19. medRxiv2021; 2021.05.14.21257218." }, { "DOI": "10.1128/AAC.49.5.1898-1906.2005", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0034", "unstructured": "Lee WA, He G-X, Eisenberg E, et al. Selective intracellular activation of a novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue. Antimicrob Agents Chemother2005; 49: 1898–906." }, { "DOI": "10.1016/S0140-6736(20)30937-5", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0035", "unstructured": "Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet2020; 395: 1417–8." }, { "DOI": "10.1101/cshperspect.a004820", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0036", "unstructured": "Lorizate M, Kräusslich H-G. Role of lipids in virus replication. Cold Spring Harb Perspect Biol2011; 3: a004820." }, { "DOI": "10.1097/QAI.0b013e3182185276", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0037", "unstructured": "Melchjorsen J, Risør MW, Søgaard OS, et al. Tenofovir selectively regulates production of inflammatory cytokines and shifts the IL-12/IL-10 balance in human primary cells. J Acquir Immune Defic Syndr2011; 57: 265–75." }, { "DOI": "10.1128/AAC.45.12.3381-3386.2001", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0038", "unstructured": "Zídek Z, Franková D, Holý A. Activation by 9-(R)-[2-(phosphonomethoxy)propyl]adenine of chemokine (RANTES, macrophage inflammatory protein 1alpha) and cytokine (tumor necrosis factor alpha, interleukin-10 [IL-10], IL-1beta) production. Antimicrob Agents Chemother2001; 45: 3381–6." }, { "DOI": "10.1097/QAI.0000000000000529", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0039", "unstructured": "Castillo-Mancilla JR, Meditz A, Wilson C, et al. Reduced immune activation during tenofovir-emtricitabine therapy in HIV-negative individuals. J Acquir Immune Defic Syndr2015; 68: 495–501." }, { "DOI": "10.1126/science.abc8511", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0040", "unstructured": "Mathew D, Giles JR, Baxter AE, et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science2020; 369. DOI:10.1126/science.abc8511." }, { "DOI": "10.1007/s40264-020-01000-8", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0041", "unstructured": "Zekarias A, Watson S, Vidlin SH, Grundmark B. Sex differences in reported adverse drug reactions to COVID-19 drugs in a global database of individual case safety reports. Drug Saf2020; 43: 1309–14." }, { "DOI": "10.1101/2021.03.24.21252635", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0042", "unstructured": "Cornejo-Giraldo M, Rosado N, Salinas J, et al. Tenofovir-DF versus Hydroxychloroquine in the treatment of hospitalized patients with COVID-19: an observational study (TEDHICOV). medRxiv2021; 2021.03.24.21252635." }, { "DOI": "10.1097/QAD.0000000000002877", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0043", "unstructured": "DeJong C, Spinelli MA, Okochi H, Gandhi M. Tenofovir-based PrEP for COVID-19: an untapped opportunity?AIDS2021; published online March 11. DOI:10.1097/QAD.0000000000002877." }, { "DOI": "10.1093/aje/kwab109", "doi-asserted-by": "crossref", "key": "10.1016/j.eclinm.2021.100993_bib0044", "unstructured": "Hernandez-Diaz S, Bateman BT, Straub L, et al. Safety of Tenofovir Disoproxil Fumarate (TDF) for pregnant women facing the COVID-19 pandemic. Am J Epidemiol2021; published online April 13. DOI:10.1093/aje/kwab109." } ], "reference-count": 44, "references-count": 44, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S258953702100273X" } }, "score": 1, "short-title": [], "source": "Crossref", "special_numbering": "C", "subject": [], "subtitle": [], "title": "Effect of Tenofovir Disoproxil Fumarate and Emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: A pilot, randomized, open-label phase 2 trial", "type": "journal-article", "update-policy": "https://doi.org/10.1016/elsevier_cm_policy", "volume": "38" }